References of "Smith, R"
     in
Bookmark and Share    
Full Text
See detailThe May 4, 2013 Stellar Occultation by Pluto and Implications for Pluto's Atmosphere
Olkin, Catherine B.; Young, L. A.; Borncamp, D. et al

in Bulletin of the American Astronomical Society (2013, October 01), 45

On May 4 2013, Pluto passed in front of a 14 star and the shadow was well observed from multiple occultation groups. This paper presents results from the three light curves observed at Las Cumbres ... [more ▼]

On May 4 2013, Pluto passed in front of a 14 star and the shadow was well observed from multiple occultation groups. This paper presents results from the three light curves observed at Las Cumbres Observatory Global Telescope Network (LCOGT) from their Cerro Tololo site. The three LCOGT telescopes have 1.0 m apertures and used identical frame-transfer cameras. The cameras currently have a 2 second readout time therefore autonomous observations were scheduled with different exposure times to give good time resolution of the event. We will present results of this occultation and compare occultation results from 1988 to 2013 with volatile transport models. [less ▲]

Detailed reference viewed: 12 (1 ULg)
Full Text
Peer Reviewed
See detailRelationship between camera physical characteristics and clinical performance of patient studies: an evaluation of two dedicated PET systems.
BENARD, F.; SMITH, R.; ALAVI, AA. et al

in Journal of Nuclear Medicine (The) (2000), 41(SUPPL), 180

Detailed reference viewed: 6 (0 ULg)
Full Text
Peer Reviewed
See detailRisedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. BMD-MN Study Group.
Fogelman, I; Ribot, C; Smith, R et al

in Journal of Clinical Endocrinology and Metabolism (2000), 85(5), 1895-900

Our objective was to investigate the efficacy and tolerability of risedronate in postmenopausal women with low bone mass. Women with a mean lumbar spine T-score of -2 or less (n = 543) received 24 months ... [more ▼]

Our objective was to investigate the efficacy and tolerability of risedronate in postmenopausal women with low bone mass. Women with a mean lumbar spine T-score of -2 or less (n = 543) received 24 months of placebo or risedronate (2.5 or 5 mg/day). All received calcium (1 g/day). The principal outcome measures were bone mineral density (BMD) at the lumbar spine, femoral neck, and femoral trochanter. At 24 months, lumbar spine BMD increased from baseline by 4% with 5 mg risedronate and 1.4% in the 2.5-mg group, compared with no change with placebo. Efficacy was similar in women who were less than 5 yr and more than 5 yr postmenopausal. At 24 months, risedronate (5 mg) had also increased BMD at the femoral neck and trochanter, whereas BMD decreased in the placebo group. BMD increases were seen at all three sites with risedronate (5 mg) after only 6 months of therapy. Risedronate was well tolerated; upper gastrointestinal adverse events were similar to placebo. We conclude that risedronate (5 mg) increases BMD rapidly and effectively and is well tolerated in postmenopausal women with low bone mass, regardless of time since menopause. [less ▲]

Detailed reference viewed: 12 (1 ULg)
Peer Reviewed
See detailRisedronate increases bone mineral density and is well-tolerated in postmenopausal women with low bone mineral density
Ribot, C; Smith, R; Fogelman, I et al

in Journal of Bone and Mineral Research (1999), 14(S1), 136

Detailed reference viewed: 9 (1 ULg)
Peer Reviewed
See detailRisedronate produces dose-dependent increases in bone mineral density in postmenopausal women with low bone mass
Fogelman, I; Ribot, C; Smith, R et al

in Calcified Tissue International (1999), 64(S1), 69

Detailed reference viewed: 7 (2 ULg)
Peer Reviewed
See detailEvaluation of the cranial rectus abdominus muscle pedicle flap as a blood supply for the caudal superficial epigastric skin flaps in dogs.
Degner, Daniel; Walshaw, Richard; Arnoczky, Steven et al

in Veterinary Surgery : The Official Journal of the American College of Veterinary Surgeons (1996), 25

Detailed reference viewed: 20 (4 ULg)